Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial membranes and cellular components represent a broad category of structural and functional elements essential for the survival and replication of pathogens such as bacteria and fungi (StatPearls: Antibiotics, 2023). This target class includes the cell wall (e.g., peptidoglycan in bacteria), the cytoplasmic membrane, and internal machinery like ribosomes (PubMed: PMCID PMC7150127). These structures maintain cellular integrity, regulate the transport of ions and nutrients, and provide a platform for energy metabolism. Because many of these components are distinct from human cellular structures, they are highly effective targets for antibiotics and antifungals. For instance, beta-lactams inhibit cell wall cross-linking, while polymyxins act as detergents on the outer membrane of Gram-negative bacteria (NIH: National Institute of Allergy and Infectious Diseases). Lipopeptides like daptomycin insert into the bacterial membrane to cause depolarization and rapid cell death. Antifungals like amphotericin B target ergosterol within the fungal membrane to create lethal pores. However, the broad nature of this target category means that drugs often face challenges related to spectrum of activity and host toxicity. Furthermore, the rapid emergence of resistance mechanisms remains a significant hurdle in targeting these components (Wikipedia: Antimicrobial resistance).
Drugs targeting these components typically act by inhibiting the synthesis of the peptidoglycan layer (e.g., glycopeptides), disrupting the phospholipid bilayer integrity (e.g., lipopeptides), forming transmembrane pores (e.g., polyenes), or binding to ribosomal subunits to halt protein production (e.g., aminoglycosides) (StatPearls: Mechanism of Action of Antibiotics).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial membranes and cellular components.